WH
WhiteOak Capital Mid Cap Fund Direct Growth
Latest NAV
+10.74% 1Y
Sign In to Add to Portfolio
Benchmark: BSE Midcap 150 TRI
Expense ratio
0.97%
AUM
₹7,485 Cr
Min SIP
₹100
Min lump sum
₹500
1Y
+10.74%
3Y (ann.)
+20.10%
5Y (ann.)
+0.00%
Launched
Sep 2022
Where the NAV sits & how risky it is
₹22.44
52-week range
at 72%
₹22.44
Low 23 Mar 2026₹18.58
High 31 Aug 2026₹23.93
Risk level
Very High
Low
Very high
NAV history
08 Sep 2022
Since inception
05 Oct 2026
Returns by period
1W
-2.92%
1M
-5.80%
3M
-0.94%
6M
+16.70%
1Y
+10.74%
3Y
+20.10%
5Y
+0.00%
3Y and 5Y returns are annualised.
Return calculator
You invest
—
Est. gain
—
Est. value
—
Invested Gain
Invested
Projected value
min SIP ₹100
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. Actual returns vary and are not guaranteed.
Where your money goes
AS OF 31 MAY 2026
Equity 86.58%
Cash & other 36.57%
Sector split
Country split
Top 5 hold 14.0%
Top 10 hold 25.6%
122 equity holdings
Equity holdings
(top 30)
| # | Holding | Sector | Country | Weight | YTD |
|---|---|---|---|---|---|
| 1 | Phoenix Mills
INE211B01039 |
Real Estate Real Estate - Diversified |
India |
3.14%
|
+1.49% |
| 2 | Max Financial Services
INE180A01020 |
Financial Services Insurance - Life |
India |
3.03%
|
-0.15% |
| 3 | Bharti Hexacom
INE343G01021 |
Communication Services Telecom Services |
India |
2.75%
|
-17.96% |
| 4 | Fortis Healthcare
INE061F01013 |
Healthcare Medical Care Facilities |
India |
2.62%
|
+8.93% |
| 5 | Coforge
INE591G01025 |
Technology Information Technology Services |
India |
2.50%
|
-11.77% |
| 6 | PB FinTech
INE417T01026 |
Financial Services Insurance Brokers |
India |
2.44%
|
-10.46% |
| 7 | Hitachi Energy
INE07Y701011 |
Industrials Electrical Equipment & Parts |
India |
2.36%
|
+101.42% |
| 8 | Federal Bank
INE171A01029 |
Financial Services Banks - Regional |
India |
2.36%
|
+21.28% |
| 9 | Bharat Heavy Electricals
INE257A01026 |
Industrials Specialty Industrial Machinery |
India |
2.19%
|
+44.15% |
| 10 | Laurus Labs
INE947Q01028 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
2.19%
|
+27.63% |
About this scheme
The primary objective of the Scheme is to seek to generate capital appreciation by actively investing in and managing a diversified portfolio primarily composed of mid-cap stocks. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.
Fund manager(s): Piyush Baranwal, Ashish Agarwal, Ramesh Mantri, Trupti Agrawal, Shariq Merchant, Dheeresh Pathak
Exit load: No charges for withdrawal
Scheme snapshot
VR Rating
MS Rating
Plan
Growth
Type
DIRECT
Inception
07 Sep 2022
Lump-sum min
₹500
SIP
Purchase
Switch
STP
SWP
Similar schemes
RANKED BY 1Y RETURN
Nippon India Taiwan Equity Fund Direct Growth
1▲ 110.8 pts ahead of this fund
Franklin Asian Equity Fund Direct Growth
2▲ 22.6 pts ahead of this fund
Nippon India Japan Equity Fund - Direct Plan - Growth Plan - Bonus Option
3▲ 19.9 pts ahead of this fund
Nippon India Japan Equity Fund Direct Growth
4▲ 19.9 pts ahead of this fund
Bank of India Small Cap Fund Direct Growth
5▲ 18.5 pts ahead of this fund
TRUSTMF Small Cap Fund Direct Growth
6▲ 18.4 pts ahead of this fund